These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26784544)

  • 1. Tetraspanin CD37 protects against the development of B cell lymphoma.
    de Winde CM; Veenbergen S; Young KH; Xu-Monette ZY; Wang XX; Xia Y; Jabbar KJ; van den Brand M; van der Schaaf A; Elfrink S; van Houdt IS; Gijbels MJ; van de Loo FA; Bennink MB; Hebeda KM; Groenen PJ; van Krieken JH; Figdor CG; van Spriel AB
    J Clin Invest; 2016 Feb; 126(2):653-66. PubMed ID: 26784544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
    Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
    Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of inactivating tetraspanin
    Elfrink S; de Winde CM; van den Brand M; Berendsen M; Roemer MGM; Arnold F; Janssen L; van der Schaaf A; Jansen E; Groenen PJTA; Eijkelenboom A; Stevens W; Hess CJ; van Krieken JH; Vermaat JSP; Cleven AHG; de Groen RAL; Neviani V; de Jong D; van Deventer S; Scheijen B; van Spriel AB
    Blood; 2019 Sep; 134(12):946-950. PubMed ID: 31366619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.
    Rops ALWMM; Jansen E; van der Schaaf A; Pieterse E; Rother N; Hofstra J; Dijkman HBPM; van de Logt AE; Wetzels J; van der Vlag J; van Spriel AB
    Kidney Int; 2018 Jun; 93(6):1356-1366. PubMed ID: 29551516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD37 expression in follicular lymphoma.
    Yoshimura T; Miyoshi H; Shimono J; Nakashima K; Takeuchi M; Yanagida E; Yamada K; Shimasaki Y; Moritsubo M; Furuta T; Kohno K; Ohshima K
    Ann Hematol; 2022 May; 101(5):1067-1075. PubMed ID: 35171311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tetraspanin CD37 orchestrates the α(4)β(1) integrin-Akt signaling axis and supports long-lived plasma cell survival.
    van Spriel AB; de Keijzer S; van der Schaaf A; Gartlan KH; Sofi M; Light A; Linssen PC; Boezeman JB; Zuidscherwoude M; Reinieren-Beeren I; Cambi A; Mackay F; Tarlinton DM; Figdor CG; Wright MD
    Sci Signal; 2012 Nov; 5(250):ra82. PubMed ID: 23150881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine.
    Arribas AJ; Gaudio E; Napoli S; Yvon Herbaux CJ; Tarantelli C; Bordone RP; Cascione L; Munz N; Aresu L; Sgrignani J; Rinaldi A; Kwee I; Rossi D; Cavalli A; Zucca E; Stussi G; Stathis A; Sloss C; Davids MS; Bertoni F
    bioRxiv; 2023 Nov; ():. PubMed ID: 38014209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity.
    van Spriel AB; Sofi M; Gartlan KH; van der Schaaf A; Verschueren I; Torensma R; Raymakers RA; Loveland BE; Netea MG; Adema GJ; Wright MD; Figdor CG
    PLoS Pathog; 2009 Mar; 5(3):e1000338. PubMed ID: 19282981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetraspanin CD37 Regulates β2 Integrin-Mediated Adhesion and Migration in Neutrophils.
    Wee JL; Schulze KE; Jones EL; Yeung L; Cheng Q; Pereira CF; Costin A; Ramm G; van Spriel AB; Hickey MJ; Wright MD
    J Immunol; 2015 Dec; 195(12):5770-9. PubMed ID: 26566675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dectin-1 interaction with tetraspanin CD37 inhibits IL-6 production.
    Meyer-Wentrup F; Figdor CG; Ansems M; Brossart P; Wright MD; Adema GJ; van Spriel AB
    J Immunol; 2007 Jan; 178(1):154-62. PubMed ID: 17182550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma.
    Elfrink S; Ter Beest M; Janssen L; Baltissen MP; Jansen PWTC; Kenyon AN; Steen RM; de Windt D; Hagemann PM; Hess C; van Spronsen DJ; Hoevenaars B; van der Spek E; Xu-Monette ZY; Young KH; Kaffa C; Bervoets S; van Heek J; Hesius E; de Winde CM; Vermeulen M; van den Brand M; Scheijen B; van Spriel AB
    Blood Adv; 2022 Apr; 6(7):2254-2266. PubMed ID: 35086136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-type lectin-like receptor 2 (CLEC-2)-dependent dendritic cell migration is controlled by tetraspanin CD37.
    de Winde CM; Matthews AL; van Deventer S; van der Schaaf A; Tomlinson ND; Jansen E; Eble JA; Nieswandt B; McGettrick HM; Figdor CG; Tomlinson MG; Acton SE; van Spriel AB
    J Cell Sci; 2018 Oct; 131(19):. PubMed ID: 30185523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37.
    Peeters R; Cuenca-Escalona J; Zaal EA; Hoekstra AT; Balvert ACG; Vidal-Manrique M; Blomberg N; van Deventer SJ; Stienstra R; Jellusova J; Giera M; Hannibal L; Spiekerkoetter U; Ter Beest M; Berkers CR; van Spriel AB
    Nat Commun; 2022 Sep; 13(1):5371. PubMed ID: 36100608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dectin-1-CD37 association regulates IL-6 expression during Toxoplasma gondii infection.
    Yan J; Wu B; Huang B; Huang S; Jiang S; Lu F
    Parasitol Res; 2014 Aug; 113(8):2851-60. PubMed ID: 24870248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.
    Pereira DS; Guevara CI; Jin L; Mbong N; Verlinsky A; Hsu SJ; Aviña H; Karki S; Abad JD; Yang P; Moon SJ; Malik F; Choi MY; An Z; Morrison K; Challita-Eid PM; Doñate F; Joseph IB; Kipps TJ; Dick JE; Stover DR
    Mol Cancer Ther; 2015 Jul; 14(7):1650-60. PubMed ID: 25934707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regulatory role for CD37 in T cell proliferation.
    van Spriel AB; Puls KL; Sofi M; Pouniotis D; Hochrein H; Orinska Z; Knobeloch KP; Plebanski M; Wright MD
    J Immunol; 2004 Mar; 172(5):2953-61. PubMed ID: 14978098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.
    Rops AL; Figdor CG; van der Schaaf A; Tamboer WP; Bakker MA; Berden JH; Dijkman HB; Steenbergen EJ; van der Vlag J; van Spriel AB
    Am J Pathol; 2010 May; 176(5):2188-97. PubMed ID: 20348240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration.
    Gartlan KH; Wee JL; Demaria MC; Nastovska R; Chang TM; Jones EL; Apostolopoulos V; Pietersz GA; Hickey MJ; van Spriel AB; Wright MD
    Eur J Immunol; 2013 May; 43(5):1208-19. PubMed ID: 23420539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.
    Zhao X; Lapalombella R; Joshi T; Cheney C; Gowda A; Hayden-Ledbetter MS; Baum PR; Lin TS; Jarjoura D; Lehman A; Kussewitt D; Lee RJ; Caligiuri MA; Tridandapani S; Muthusamy N; Byrd JC
    Blood; 2007 Oct; 110(7):2569-77. PubMed ID: 17440052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.
    Bobrowicz M; Kubacz M; Slusarczyk A; Winiarska M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.